Asco Association

“During the reporting year, the board of directors delegated authority to act on its behalf to the executive committee of the board of directors, consistent with the association's bylaws. Pursuant to the bylaws, the voting members of the executive committee are the chair, treasurer, and one or more voting members of the board of directors. The ceo is a non-voting member of the executive committee. All executive committee members are members of the association's board of directors. The scope of the executive committee's authority is established by the association's executive committee charter, which was approved by the association's board of directors. The charter provides that, except to the extent specifically prohibited by the bylaws, resolution of the board of directors, or applicable law, the executive committee is empowered to make and implement major decisions between board meetings and it may act on items requiring action prior to the next announced board meeting. All actions of the executive committee are reported to the board of directors at the next meeting of the board of directors.”

“Dr. Clifford hudis, linda jensen, and melissa tai were all employed by the association's affiliate, the american society of clinical oncology (the society), a section 501(c)(3) public charity. Dr. Hudis is the chief executive officer of the society and ms. Jensen is the chief financial officer and executive vice president of the society. Dr. Monica bertagnolli, dr. Howard burris, iii, dr. Eric small, dr. A. William blackstock, dr. Lee ellis, dr. Laurie gaspar, dr. Reshma jagsi, dr. Michael kosty, dr. Elizabeth mittendorf, dr. Tony mok, dr. Lori pierce, dr. Everett vokes, dr. Tracey weisberg, and dr. Eric winer all served as voting members of the society's board of directors during the tax year. In addition, during the tax year, dr. Bertagnolli served as past president of the society, dr. Burris served as chair of the board and past president of the society, dr. Pierce served as president and chair of the board of the society, dr. Vokes served as president-elect and president of the society, dr. Winer served as president-elect of the society, dr. Gaspar served as treasurer of the society, and dr. Mittendorf served as treasurer-elect of the society.”

“In 2021, the association's bylaws were amended. Significant changes included the following: *modifying the voting rights of members previously, only those members classified as full members, emeritus members, and honorary members had voting rights. The bylaws were amended to permit all oncology medical professional members who have been awarded and hold the degree of doctor of medicine, doctor of osteopathy, doctor of philosophy, doctor of pharmacy, doctor of medical science, doctor of nursing science, doctor of nursing practice, or equivalent doctoral-level degree the right to vote; *expanding actions that the association may take during member discipline procedures; *permitting members to attend meetings by means of remote communication; *permitting members to take action by written consent; and *adding the treasurer-elect of the society as an ex-officio voting member of the association's board of directors.”

“None of the association's members has the right to receive a share of the organization's profits or excess dues or a share of the organization's net assets upon dissolution. Membership is limited to oncology medical professionals, defined as individuals whose professional credentials and activities involve cancer patient care and/or research, education, or advocacy in the biology, diagnosis, prevention, or treatment of human cancer; those individuals who are retired from professional activities, but whose professional activities prior to retirement included those described above; and those individuals who are students training to be professionals described above. The category of membership with voting rights is voting members, who are defined as those oncology medical professional members that have been awarded and hold the degree of doctor of medicine, doctor of osteopathy, doctor of philosophy, doctor of pharmacy, doctor of medical science, doctor of nursing science, doctor of nursing practice, or equivalent doctoral-level degree.”

“All asco members are members of both the association and its affiliate, the american society of clinical oncology (the society). Voting members of asco elect all members of the society board of directors. The members of the society board of directors who are in the final year of their terms, and the society's elected officers, who are all elected by the asco voting members, serve as ex-officio voting members of the association board of directors. The category of asco members who are eligible to vote for the election of members of the society board of directors are voting members, who are defined as those oncology medical professional members that have been awarded and hold the degree of doctor of medicine, doctor of osteopathy, doctor of philosophy, doctor of pharmacy, doctor of medical science, doctor of nursing science, doctor of nursing practice, or equivalent doctoral-level degree.”

“Voting members have the right to vote on changing the purpose of the association (as set forth in the bylaws), voluntary dissolution of the association, and any such matters that the board of directors brings to the membership for vote.”

“A draft electronic copy of the association's form 990 was sent, through a secure site, to each member of the board of directors. In addition, before filing, the form was reviewed by the cfo and chief legal officer.”

“The association maintains a number of written conflict of interest policies and standards regarding the disclosure and management of conflicts of interest. These policies and standards cover all association members and employees, directors, officers, committee members, and any person in a relationship with these individuals involving the sharing of income or assets (e.g. Spouse, dependent children). Covered individuals are asked to disclose financial interests in or other relationships with entities that have relevant commercial interests, including employment or leadership positions, consultant or advisory roles, stock ownership, honoraria, research funding, and service as an expert witness. Officers, directors and key employees are also required to disclose service as an officer, director, or trustee of any other professional or advocacy organization relating to science or health care. Completion of a disclosure form is required at the initiation of service and updated annually thereafter or when any material changes occur. The association's conflict of interest policies are intended to help guide the management of actual, potential, and perceived conflicts of interest through disclosure of financial interests or other relationships. Where the nature and extent of a financial relationship suggest disclosure is not adequate to manage a real or potential conflict, covered individuals are required to recuse themselves from decision making. Recusal may be self-selected, or may be requested by the committee chair, officer, or executive-level staff members. In addition, if the association were to contemplate entering into a transaction or arrangement that might benefit the private interest of any interested person (i.e. A board member, director, principal officer, or key employee who has a direct or indirect financial interest in the transaction), it must follow a specific procedure to manage the conflict, including considering alterative transactions that would not give rise to a conflict of interest.”

“The compensation of the association's vice president of member services was reviewed and approved by independent persons on the basis of comparability data, and the deliberation and decision was contemporaneously substantiated. The association's compensation consultant, based on the role's responsibilities and comparability data, provided reasonableness assurance for such compensation. This review was last conducted in 2021.”

“The association's articles of incorporation are available on the virginia state corporation commission website. The association makes its bylaws available upon request. The association's conflict of interest policy is available on the asco website. The association's financial statements are not made available to the public.”

“The chief executive officer of the association is an employee of the association's affiliate, the american society of clinical oncology (the society). Information regarding his compensation and the process for determining his compensation, including review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision, are described in the irs form 990 of the society. The association reimburses the society for time spent on association matters in accordance with a shared services agreement between the entities.”